MedTrace Logo

Financing Strategies of Influenza Vaccination in China

NCT04038333 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13542

Last updated 2022-01-24

No results posted yet for this study

Summary

This trial focuses on influenza vaccination among three recommended groups in China. Data concerning the economic burden of influenza-like illness (ILI), vaccine hesitancy, discrete choice experiment, immunization records and willingness to pay for vaccines will be collected via questionnaires, and the financing strategies of influenza vaccines in China will be further analyzed. Besides, the knowledge, attitude/belief and practice (KAP) of medical staff will also be asked in a supplementary questionnaire.

Conditions

  • Influenza Vaccines
  • Influenza, Human
  • Cost of Illness
  • Health Knowledge, Attitudes, Practice
  • Immunization Programs

Interventions

OTHER

No intervention

This is an observational study without any interventions.

Sponsors & Collaborators

  • Centers for Disease Control and Prevention, China

    collaborator OTHER_GOV

  • Fudan University

    collaborator OTHER

  • Shandong University

    collaborator OTHER

  • Peking University

    lead OTHER

Principal Investigators

  • Hai Fang, PhD · Peking University

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2019-10-30
Completion
2021-03-10

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04038333 on ClinicalTrials.gov